Successful use of a selective serotonin reuptake inhibitor in a patient with multiple chemical sensitivities.
A 53-year-old man with multiple chemical sensitivities (MCS) received the selective serotonin reuptake inhibitor (SSRI) citalopram for treatment of depression. The treatment was successful and, in parallel to the remission of the depressive symptoms, all MCS symptoms vanished. This suggests that a subgroup of MCS patients may have an atypical depression, that they should be psychiatrically evaluated, and that antidepressive pharmacological treatment may be considered in cases of MCS.
Andiné
P
P
Department of Psychiatry, Institute of Clinical Neuroscience, Sahlgrenska University Hospital, Göteborg, Sweden.
Rönnbäck
L
L
Järvholm
B
B
D000336:Aerosols / Q000009:adverse effects; D018687:Antidepressive Agents, Second-Generation / Q000627:therapeutic use*; D015283:Citalopram / Q000627:therapeutic use*; D003863:Depression / Q000150:complications* / Q000188:drug therapy; D006801:Humans; D008297:Male; D008875:Middle Aged; D018777:Multiple Chemical Sensitivity / Q000145:classification / Q000188:drug therapy* / Q000209:etiology; D016273:Occupational Exposure / Q000009:adverse effects; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use*; D012997:Solvents / Q000009:adverse effects
D000336:Aerosols; D018687:Antidepressive Agents, Second-Generation; D015283:Citalopram; D017367:Selective Serotonin Reuptake Inhibitors; D012997:Solvents